Plainfield, NJ, United States of America

Joseph E Lynch

This inventor holds 34 USPTO granted patents and 3 published patent applications and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp.. Active years: 1986-2023.

USPTO Granted Patents = 34 (Patent Applications = 3)

% Patents Active = 97.1

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 5.5

ph-index = 9

Forward Citations = 215(Granted Patents)

Location History:

Plainsboro, NJ (US) (2015 - 2018)
Plainfield, NJ (US) (1986 - 2023)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

where one patent can have more than one assignee

Years Active: 1986-2023

Loading Chart...

Areas of Expertise:

Beta 3 Agonists

CGRP Antagonists

HMG-CoA Reductase

Phosphodiesterase IV

Peptide Intermediates

Prostate Cancer

Carbapenem Intermediates

Chiral Synthesis

Oxidation Reduction

Growth Hormone Secretagogue

Nitrogen Deprotection

Stereoselective Synthesis

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11767292 - Process for making beta 3 agonists and intermediates (2023-09-26),

2. 11708371 - Process for making beta 3 agonists and intermediates (2023-07-25),

3. 11124478 - Process for making beta 3 agonists and intermediates (2021-09-21),

4. 10899771 - Process for making beta 3 agonists and intermediates (2021-01-26),

5. 10577316 - Process for making beta 3 agonists and intermediates (2020-03-03),

6. 10435410 - Process for making beta 3 agonists and intermediates (2019-10-08),

7. 10106541 - Intermediates for preparing CGRP receptor antagonists (2018-10-23),

8. 10087189 - Process for making beta 3 agonists and intermediates (2018-10-02),

9. 9850246 - Process for making CGRP receptor antagonists (2017-12-26),

10. 9822121 - Process for making beta 3 agonists and intermediates (2017-11-21),

11. 9809536 - Process for making beta 3 agonists and intermediates (2017-11-07),

12. 9174989 - Process for making CGRP receptor antagonists (2015-11-03),

13. 8618112 - Crystalline forms of an inhibitor of 11-β-hydroxysteroid dehydrogenase type 1 (2013-12-31),

14. 7875642 - Crystalline forms of an inhibitor of 11-β-hydroxysteroid dehydrogenase type 1 (2011-01-25),

15. 7262169 - Process for preparing peptide intermediates (2007-08-28),

Title: The Innovator Behind 34 Patents: Joseph E Lynch

Introduction: Meet Joseph E Lynch, a prolific inventor hailing from Plainfield, NJ, with an impressive portfolio of 34 patented inventions to his name. His groundbreaking work has left a lasting impact on the fields of pharmaceuticals and healthcare.

Latest Patents: Among his recent patents is the innovative "Process for making beta 3 agonists and intermediates." This cutting-edge process involves multiple-step reactions to prepare compounds that are crucial in the treatment of disorders such as overactive bladder, urinary incontinence, and urinary urgency.

Career Highlights: Joseph E Lynch has made significant contributions during his tenure at esteemed companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His expertise and dedication have played a vital role in shaping advancements in the pharmaceutical industry.

Collaborations: Throughout his career, Joseph E Lynch has collaborated with industry experts such as Ralph P Volante and Nobuyoshi Yasuda. Together, they have worked on various projects that have pushed the boundaries of scientific innovation.

Conclusion: Joseph E Lynch stands out as a visionary inventor whose passion for excellence has led to the development of numerous groundbreaking technologies. His relentless pursuit of innovation continues to inspire generations of inventors and researchers in the quest for scientific advancement.